From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

Ann Graham of MIB Agents discussed some of the challenges adolescent and young adult patients deal with after cancer diagnoses.

Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.

I've learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

An expert explained recent findings from a study of pregnant women with breast cancer who underwent chemotherapy and fared ...

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma ...

One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...

A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and ...

NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received ...